Spots Global Cancer Trial Database for immunotherapy esophagus cancer
Every month we try and update this database with for immunotherapy esophagus cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma | NCT05515315 | Immunotherapy E... | Tislelizumab Albumin paclita... Nedaplatin radiotherapy | 18 Years - 70 Years | Fuzhou General Hospital | |
| Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma | NCT05515315 | Immunotherapy E... | Tislelizumab Albumin paclita... Nedaplatin radiotherapy | 18 Years - 70 Years | Fuzhou General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
